St. Louis, MO, United States of America

Richard J Stonard

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard J Stonard. Retrieved from https://idiyas.com/inventor/richard-j-stonard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Richard J Stonard

Introduction

Richard J Stonard is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of pharmaceuticals, particularly in wound healing. His innovative approach has led to the development of a unique composition that aids in the healing process.

Latest Patents

Stonard holds a patent for a wound-healing composition. This pharmaceutical dosage unit includes a wound-healing amount of an aporphinoid alkaloid, such as taspine free acid, dissolved in a physiologically tolerable non-aqueous solvent like dimethylsulfoxide. This invention showcases his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Stonard has focused on creating effective solutions for medical challenges. His work has been recognized for its potential impact on patient care and recovery. With 1 patent to his name, he continues to explore new avenues in pharmaceutical innovation.

Collaborations

Stonard has collaborated with notable colleagues, including Walter H Lewis and Beatriz Porras-Reyes. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions.

Conclusion

Richard J Stonard's contributions to the field of wound healing exemplify the spirit of innovation. His work not only addresses critical medical needs but also inspires future advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…